.png
)
⚡ Breaking · Gazette Extraordinary, June 15, 2026 | Immediate Effect Regulatory Action Centre Bans 16 Fixed Dose Combinations Under Section 26A of Drugs & Cosmetics Act The Ministry of Health and Family Welfare has prohibited the manufacture, sale and…
4th June, 2026 Drugs Controller General of India (DCGI), issued a formal circular directing all drug manufacturers and all stakeholders to ensure they have a working pharmacovigilance (PV) system in place — one that is fully compliant with the Drugs…
The Ministry of Health and Family Welfare has formally added the widely used nerve-pain drug Pregabalin to Schedule H1 of the Drugs Rules, 1945 — a category reserved for substances with high abuse potential. The Government of India has officially…
Central Drugs Standard Control Organisation (CDSCO) in its latest notification has moved to tighten oversight of the booming cosmetics industry in India, issuing unambiguous guidance on what constitutes a cosmetic product, how it may lawfully be used, and what actions…
The Central Drugs Standard Control Organization (CDSCO), operating under the Directorate General of Health Services, Government of India, has issued a sweeping directive to all State and Union Territory Drug Controllers, calling for urgent and coordinated enforcement action against the…